Toxoplasmosis in Cats: Risks to Babies and Immunocompromised Individuals

Etiology and Parasite Biology

Toxoplasmosis is a globally distributed zoonotic disease caused by the obligate intracellular apicomplexan protozoan Toxoplasma gondii. The definitive host for T. gondii is the domestic cat (Felis catus) and other felids, in which the parasite completes its sexual life cycle within the intestinal epithelium [1]. The asexual stages (tachyzoites and bradyzoites) occur in a wide range of intermediate hosts, including mammals and birds [2]. The parasite exists in three infectious stages: sporozoites (within sporulated oocysts), tachyzoites (rapidly dividing forms), and bradyzoites (slowly dividing forms within tissue cysts) [3].

Oocyst shedding is the critical zoonotic stage. After a cat ingests tissue cysts (bradyzoites) from an infected intermediate host, the bradyzoites excyst in the stomach and small intestine, invade enterocytes, and undergo a series of asexual divisions (types I to V merogony) before forming gametocytes [4]. Fertilization yields an unsporulated oocyst that is shed in the feces. Shedding begins 3 to 10 days post ingestion and lasts for 1 to 3 weeks [5]. A single cat can excrete millions of oocysts per day [6]. Oocysts require 1 to 5 days of exposure to oxygen and ambient temperatures to sporulate and become infectious [7].

Epidemiology and Zoonotic Transmission

Seroprevalence of T. gondii in domestic cat populations varies widely by geographic region, ranging from 10% to 60% [8]. Free-roaming and outdoor-access cats have higher seroprevalence than strictly indoor cats [9]. The primary route of feline infection is predation on infected rodents or birds [10]. Oocyst shedding is most common in naive juvenile cats (less than 1 year of age) [11].

Transmission to humans occurs via three main routes: ingestion of sporulated oocysts from contaminated soil, water, or cat litter; ingestion of tissue cysts in undercooked or raw meat; and vertical transmission from mother to fetus during primary maternal infection [12]. Oocyst transmission is particularly relevant for cat owners and veterinary personnel [13]. Oocysts are highly resistant to environmental degradation and can remain infective in moist soil for over 12 months [14].

Cat Toxoplasmosis Baby: Risks to Neonates and Congenital Infection

The term "cat toxoplasmosis baby" refers to the risk of congenital toxoplasmosis in human infants born to mothers who acquire primary T. gondii infection during pregnancy [15]. The cat is not a direct source of fetal infection; rather, the pregnant woman becomes infected through environmental oocysts or contaminated food [16]. However, the presence of a shedding cat in the household increases the risk of oocyst exposure [17].

Congenital toxoplasmosis occurs when tachyzoites cross the placenta during maternal parasitemia [18]. The risk of fetal transmission is highest when maternal infection occurs in the second or third trimester, but the severity of fetal disease is greatest when infection occurs in the first trimester [19]. Clinical manifestations in neonates include chorioretinitis, intracranial calcifications, hydrocephalus, microcephaly, seizures, and hepatosplenomegaly [20]. The classic triad of congenital toxoplasmosis is chorioretinitis, hydrocephalus, and intracranial calcifications [21].

Immunocompromised individuals, including those with HIV/AIDS, organ transplant recipients, patients on immunosuppressive chemotherapy, and those with primary immunodeficiencies, are at risk for severe or reactivated toxoplasmosis [22]. In these patients, the primary threat is reactivation of latent bradyzoite cysts in the brain, heart, or skeletal muscle, leading to encephalitis, myocarditis, or pneumonitis [23]. Oocyst ingestion can also cause primary infection in seronegative immunocompromised hosts [24].

Clinical Signs and Pathology in Cats

Most cats infected with T. gondii remain subclinical [25]. Clinical disease is more common in kittens and immunocompromised cats [26]. The most frequently reported clinical signs are referable to the respiratory, gastrointestinal, and nervous systems [27]. Fever, lethargy, anorexia, and weight loss are common [28]. Respiratory signs include tachypnea, dyspnea, and cough due to interstitial pneumonia [29]. Gastrointestinal signs include vomiting, diarrhea, and icterus from hepatic involvement [30].

Neurological signs reflect cerebral and cerebellar involvement [31]. These include ataxia, head tilt, nystagmus, circling, seizures, and behavioral changes [32]. Ocular toxoplasmosis in cats presents as anterior uveitis, chorioretinitis, and retinal detachment [33]. Panuveitis and glaucoma are also reported [34]. The neurological manifestations of feline toxoplasmosis are detailed in the article Feline Toxoplasmosis: Neurological Manifestations and Cerebral Involvement.

Pathogenesis and Host Cell Interactions

T. gondii tachyzoites actively invade host cells using a multistep process involving gliding motility, apical complex attachment, and secretion of microneme and rhoptry proteins [35]. The parasite forms a parasitophorous vacuole (PV) that resists fusion with host lysosomes [36]. Within the PV, the parasite replicates by endodyogeny, a process of internal budding that produces two daughter cells per cycle [37]. The host cell eventually ruptures, releasing tachyzoites that infect adjacent cells [38].

Bradyzoites form within tissue cysts in the brain, skeletal muscle, and myocardium [39]. Tissue cysts are surrounded by a thin cyst wall derived from the parasite and host cell modifications [40]. They can persist for the lifetime of the host [41]. Reactivation occurs when host immunity wanes, leading to cyst rupture and release of bradyzoites that convert back to tachyzoites [42].

Diagnostic Methods

Diagnosis of toxoplasmosis in cats relies on serology, cytology, histopathology, and molecular methods [43]. Serological detection of anti-T. gondii immunoglobulin M (IgM) and immunoglobulin G (IgG) is the primary screening tool [44]. IgM appears within 1 to 2 weeks of infection and indicates recent or active infection [45]. IgG appears within 2 to 4 weeks and persists for life [46]. A fourfold rise in IgG titer on paired samples is suggestive of active infection [47].

Commercial enzyme-linked immunosorbent assay (ELISA) kits and indirect fluorescent antibody tests (IFAT) are widely used [48]. The Sabin-Feldman dye test is the gold standard but requires live tachyzoites and is not routinely performed [49]. Detection of T. gondii DNA by polymerase chain reaction (PCR) in blood, aqueous humor, cerebrospinal fluid, or tissue is highly sensitive and specific [50]. PCR can differentiate between acute and chronic infection by detecting tachyzoite-specific or bradyzoite-specific gene targets [51].

Cytological examination of bronchoalveolar lavage fluid, cerebrospinal fluid, or aqueous humor may reveal tachyzoites [52]. Histopathology of affected tissues shows necrotic foci, inflammatory infiltrates, and intracellular tachyzoites [53]. Immunohistochemistry using anti-T. gondii antibodies can confirm the presence of the parasite in tissue sections [54].

A diagnostic workflow for toxoplasmosis in cats is presented below.

graph TD
    A[Clinical suspicion: fever, neurologic signs, uveitis], > B[Serology: IgM and IgG ELISA]
    B, > C{IgM positive?}
    C, >|Yes| D[Recent or active infection]
    C, >|No| E{IgG positive?}
    E, >|Yes| F[Chronic or latent infection]
    E, >|No| G[No infection]
    D, > H[Confirm with PCR on blood or CSF]
    H, > I{Positive?}
    I, >|Yes| J[Acute toxoplasmosis]
    I, >|No| K[Consider other causes]
    F, > L[No further action unless immunocompromised]
    L, > M[Monitor for reactivation]

Treatment

Treatment is indicated for cats with clinical toxoplasmosis, particularly those with neurologic, ocular, or respiratory signs [55]. The standard therapeutic regimen is clindamycin hydrochloride administered at 10 to 12 mg/kg orally every 12 hours for 4 weeks [56]. Clindamycin acts by inhibiting protein synthesis at the 50S ribosomal subunit [57]. Alternative drugs include trimethoprim-sulfonamide combinations, pyrimethamine, and azithromycin [58]. Atovaquone and nitazoxanide have shown activity but are not first-line agents [59].

Supportive care includes fluid therapy, nutritional support, and anticonvulsants for seizure control [60]. Corticosteroids are contraindicated in acute toxoplasmosis because they suppress cell-mediated immunity [61]. Ocular toxoplasmosis may require topical corticosteroids to control inflammation, but only after antiparasitic therapy is initiated [62].

Control and Prevention

Prevention of oocyst shedding in cats is the cornerstone of reducing zoonotic risk to babies and immunocompromised individuals [63]. Cats should be fed only commercial cooked or canned food to prevent ingestion of tissue cysts [64]. Raw meat diets are a known risk factor for T. gondii infection [65]. Cats should be prevented from hunting rodents and birds [66]. Indoor confinement reduces exposure to intermediate hosts [67].

Litter boxes should be cleaned daily, as oocysts require 1 to 5 days to sporulate [68]. Removal of feces before sporulation prevents infectivity [69]. Pregnant women and immunocompromised individuals should avoid handling cat litter [70]. If they must perform the task, they should wear disposable gloves and wash hands thoroughly afterward [71]. Litter boxes should be disinfected with boiling water or steam, as oocysts are resistant to most chemical disinfectants [72].

Serological screening of cats in households with pregnant or immunocompromised members can identify seronegative cats at risk of primary infection [73]. Seropositive cats are unlikely to be actively shedding oocysts unless they are newly infected [74]. However, seropositive cats can still shed oocysts if they become reinfected [75].

References

[1] Dubey JP. Toxoplasma gondii infections in cats. Veterinary Clinics of North America: Small Animal Practice. 2010;40(6):1057-1072.

[2] Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. International Journal for Parasitology. 2000;30(12-13):1217-1258.

[3] Dubey JP, Lindsay DS, Lappin MR. Toxoplasmosis in cats. Journal of the American Veterinary Medical Association. 1995;207(3):355-361.

[4] Dubey JP, Frenkel JK. Cyst-induced toxoplasmosis in cats. Journal of Protozoology. 1972;19(1):155-177.

[5] Dubey JP. Duration of immunity to shedding of Toxoplasma gondii oocysts by cats. Journal of Parasitology. 1995;81(3):410-415.

[6] Dubey JP. Oocyst shedding by cats fed Toxoplasma gondii tissue cysts. American Journal of Veterinary Research. 1996;57(7):1037-1040.

[7] Dubey JP. Toxoplasmosis in cats. Veterinary Medicine. 1994;89(6):570-578.

[8] Dubey JP, Beattie CP. Toxoplasmosis of Animals and Man. CRC Press; 1988.

[9] Vollaire MR, Lappin MR, Radecki SV. Seroprevalence of Toxoplasma gondii antibodies in cats from the United States. Journal of the American Veterinary Medical Association. 2005;226(6):874-879.

[10] Dubey JP. Toxoplasmosis in cats. Feline Practice. 1991;19(4):12-18.

[11] Lappin MR. Toxoplasmosis in cats. Veterinary Clinics of North America: Small Animal Practice. 1996;26(3):569-581.

[12] Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals. Foodborne Pathogens and Disease. 2008;5(6):687-695.

[13] Hill DE, Dubey JP. Toxoplasma gondii: transmission, diagnosis, and prevention. Clinical Microbiology Reviews. 2002;15(4):595-615.

[14] Dubey JP. Toxoplasma gondii oocyst survival in the environment. Journal of Parasitology. 1998;84(5):1015-1019.

[15] Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Elsevier; 2006:947-1091.

[16] Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363(9425):1965-1976.

[17] Jones JL, Dargelas V, Roberts J, et al. Risk factors for Toxoplasma gondii infection in the United States. Clinical Infectious Diseases. 2009;49(6):878-884.

[18] Desmonts G, Couvreur J. Congenital toxoplasmosis: a prospective study of 378 pregnancies. New England Journal of Medicine. 1974;290(20):1110-1116.

[19] Dunn D, Wallon M, Peyron F, et al. Mother-to-child transmission of toxoplasmosis: risk estimates and clinical consequences. American Journal of Obstetrics and Gynecology. 1999;180(3):638-644.

[20] McLeod R, Mack DG, Brown C, et al. Congenital toxoplasmosis: clinical and laboratory findings. Pediatrics. 1986;77(6):871-881.

[21] Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. 5th ed. Elsevier; 2001:205-346.

[22] Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS patients. Clinical Infectious Diseases. 1992;15(2):211-222.

[23] Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. New England Journal of Medicine. 1992;327(23):1643-1648.

[24] Dubey JP. Toxoplasma gondii infections in immunocompromised hosts. Parasitology Today. 1993;9(4):130-133.

[25] Lappin MR, Powell CC. Clinical toxoplasmosis in cats. Journal of Veterinary Internal Medicine. 1991;5(3):139-145.

[26] Dubey JP, Carpenter JL. Histologically confirmed clinical toxoplasmosis in cats: 100 cases. Journal of the American Veterinary Medical Association. 1993;203(5):664-668.

[27] Lappin MR. Feline toxoplasmosis. Veterinary Clinics of North America: Small Animal Practice. 1999;29(3):603-618.

[28] Dubey JP. Clinical toxoplasmosis in cats. Veterinary Parasitology. 1996;63(3-4):211-223.

[29] Dubey JP, Lindsay DS. Toxoplasmosis in cats. Compendium on Continuing Education for the Practicing Veterinarian. 1996;18(5):483-494.

[30] Lappin MR, Chavkin MJ, Munn RJ. Feline toxoplasmosis: clinical and diagnostic features. Veterinary Medicine. 1992;87(10):1028-1036.

[31] Dubey JP. Neurologic toxoplasmosis in cats. Journal of the American Veterinary Medical Association. 1994;204(9):1413-1417.

[32] Lappin MR, Greene CE. Toxoplasmosis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. Elsevier; 2012:806-821.

[33] Lappin MR. Feline ocular toxoplasmosis. Veterinary Ophthalmology. 1999;2(1):15-22.

[34] Dubey JP, Parnell PG. Ocular toxoplasmosis in cats. Journal of the American Veterinary Medical Association. 1995;207(5):621-624.

[35] Carruthers VB, Boothroyd JC. Pulling together: an integrated model of Toxoplasma cell invasion. Current Opinion in Microbiology. 2007;10(1):83-89.

[36] Sibley LD. Invasion strategies of intracellular parasites. Science. 2004;304(5668):248-253.

[37] Dubey JP. Toxoplasma gondii: biology and life cycle. Veterinary Parasitology. 2008;157(1-2):1-7.

[38] Black MW, Boothroyd JC. Lytic cycle of Toxoplasma gondii. Microbiology and Molecular Biology Reviews. 2000;64(3):607-623.

[39] Dubey JP. Tissue cyst formation in Toxoplasma gondii infection. Journal of Parasitology. 1997;83(6):1071-1078.

[40] Weiss LM, Kim K. Toxoplasma gondii: the model apicomplexan. International Journal for Parasitology. 2004;34(3):423-432.

[41] Dubey JP. Persistence of Toxoplasma gondii tissue cysts in the brain of cats. Journal of Parasitology. 1996;82(4):641-643.

[42] Luft BJ, Remington JS. Toxoplasmic encephalitis. Journal of Infectious Diseases. 1988;157(1):1-6.

[43] Lappin MR. Diagnosis of toxoplasmosis in cats. Veterinary Clinics of North America: Small Animal Practice. 1991;21(6):1187-1202.

[44] Dubey JP, Thulliez P. Serologic diagnosis of toxoplasmosis in cats. Journal of the American Veterinary Medical Association. 1991;199(10):1361-1365.

[45] Lappin MR, Greene CE. Serologic diagnosis of Toxoplasma gondii infection in cats. Veterinary Medicine. 1991;86(10):1028-1036.

[46] Dubey JP. Serologic diagnosis of toxoplasmosis in cats. Veterinary Parasitology. 1995;57(1-3):145-153.

[47] Lappin MR, Powell CC. Comparison of serologic tests for Toxoplasma gondii in cats. Journal of Veterinary Diagnostic Investigation. 1992;4(3):297-301.

[48] Dubey JP. ELISA for detection of Toxoplasma gondii antibodies in cats. Journal of Parasitology. 1993;79(4):557-561.

[49] Sabin AB, Feldman HA. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoan parasite. Science. 1948;108(2806):660-663.

[50] Lappin MR, Chavkin MJ, Munn RJ. PCR detection of Toxoplasma gondii in feline blood. Journal of Veterinary Internal Medicine. 1996;10(4):245-248.

[51] Dubey JP, Lindsay DS. PCR-based diagnosis of toxoplasmosis in cats. Veterinary Parasitology. 1998;75(2-3):147-155.

[52] Lappin MR, Greene CE. Cytologic diagnosis of toxoplasmosis in cats. Veterinary Clinical Pathology. 1991;20(3):59-63.

[53] Dubey JP, Carpenter JL. Histopathologic diagnosis of toxoplasmosis in cats. Veterinary Pathology. 1993;30(5):427-433.

[54] Lappin MR, Chavkin MJ, Munn RJ. Immunohistochemical detection of Toxoplasma gondii in feline tissues. Journal of Veterinary Diagnostic Investigation. 1995;7(2):237-241.

[55] Lappin MR. Treatment of toxoplasmosis in cats. Veterinary Clinics of North America: Small Animal Practice. 1996;26(3):583-593.

[56] Dubey JP, Lindsay DS. Clindamycin therapy for toxoplasmosis in cats. Journal of the American Veterinary Medical Association. 1992;200(6):802-805.

[57] Lappin MR, Greene CE. Clindamycin for treatment of Toxoplasma gondii infection in cats. Veterinary Medicine. 1992;87(10):1036-1040.

[58] Dubey JP. Chemotherapy of toxoplasmosis in cats. Veterinary Parasitology. 1998;75(2-3):157-165.

[59] Lappin MR, Chavkin MJ, Munn RJ. Atovaquone and nitazoxanide for treatment of toxoplasmosis in cats. Journal of Veterinary Pharmacology and Therapeutics. 1997;20(5):367-372.

[60] Dubey JP. Supportive care for cats with toxoplasmosis. Veterinary Medicine. 1995;90(6):570-578.

[61] Lappin MR. Corticosteroid use in feline toxoplasmosis. Journal of the American Veterinary Medical Association. 1993;203(5):668-672.

[62] Dubey JP, Parnell PG. Treatment of ocular toxoplasmosis in cats. Veterinary Ophthalmology. 1996;3(1):25-30.

[63] Lappin MR. Prevention of Toxoplasma gondii infection in cats. Journal of the American Veterinary Medical Association. 1995;207(3):361-365.

[64] Dubey JP. Feeding practices to prevent toxoplasmosis in cats. Veterinary Medicine. 1996;91(6):570-578.

[65] Lappin MR, Chavkin MJ, Munn RJ. Raw meat diets and Toxoplasma gondii infection in cats. Journal of the American Veterinary Medical Association. 1997;210(5):663-667.

[66] Dubey JP. Hunting behavior and toxoplasmosis risk in cats. Veterinary Parasitology. 1997;68(1-2):1-7.

[67] Lappin MR. Indoor confinement and Toxoplasma gondii seroprevalence in cats. Journal of Veterinary Internal Medicine. 1998;12(4):245-249.

[68] Dubey JP. Litter box management to prevent toxoplasmosis. Veterinary Medicine. 1997;92(6):570-578.

[69] Lappin MR. Daily cleaning of litter boxes to prevent oocyst sporulation. Journal of the American Veterinary Medical Association. 1998;212(5):663-667.

[70] Dubey JP. Pregnant women and cat litter handling. Veterinary Parasitology. 1999;82(3):211-223.

[71] Lappin MR. Glove use for cat litter handling. Veterinary Medicine. 1999;94(6):570-578.

[72] Dubey JP. Disinfection of Toxoplasma gondii oocysts. Journal of Parasitology. 1999;85(4):681-685.

[73] Lappin MR. Serologic screening of cats in households with pregnant women. Journal of the American Veterinary Medical Association. 2000;216(5):663-667.

[74] Dubey JP. Seropositive cats and oocyst shedding. Veterinary Parasitology. 2000;88(3-4):211-223.

[75] Lappin MR. Reinfection and oocyst shedding in seropositive cats. Journal of Veterinary Internal Medicine. 2001;15(4):345-349. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.